Eva Fortea Verdejo's Stock Ratings

Wells Fargo Analyst

Eva Fortea Verdejo is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/18/2025

Overall Average Return

5.32%

Smart Score

56.2%

Overall Average Return Percentile

49th

Number of Ratings

14
Buy NowGet Alert
05/28/2025ITOSBuy Now
ITeos Therapeutics
$10.0020%
Eva Fortea Verdejo56%
$13 → $12DowngradeOverweight → Equal-WeightGet Alert
05/23/2025BCAXBuy Now
Bicara Therapeutics
$9.29-13.93%
Eva Fortea Verdejo56%
$8 → $8UpgradeUnderweight → Equal-WeightGet Alert
05/14/2025ITOSBuy Now
ITeos Therapeutics
$10.0030%
Eva Fortea Verdejo56%
$16 → $13MaintainsOverweightGet Alert
05/08/2025MRUSBuy Now
Merus
$52.5969.23%
Eva Fortea Verdejo56%
$91 → $89MaintainsOverweightGet Alert
05/07/2025RCUSBuy Now
Arcus Biosciences
$8.51205.52%
Eva Fortea Verdejo56%
$29 → $26MaintainsOverweightGet Alert
04/29/2025ITOSBuy Now
ITeos Therapeutics
$10.0060%
Eva Fortea Verdejo56%
$17 → $16MaintainsOverweightGet Alert
04/17/2025BCAXBuy Now
Bicara Therapeutics
$9.29-13.93%
Eva Fortea Verdejo56%
→ $8Initiates → UnderweightGet Alert
03/06/2025ITOSBuy Now
ITeos Therapeutics
$10.0070%
Eva Fortea Verdejo56%
$19 → $17MaintainsOverweightGet Alert
02/28/2025XNCRBuy Now
Xencor
$8.36294.74%
Eva Fortea Verdejo56%
$37 → $33MaintainsOverweightGet Alert
12/19/2024ITOSBuy Now
ITeos Therapeutics
$10.0090%
Eva Fortea Verdejo56%
$31 → $19MaintainsOverweightGet Alert
12/12/2024XNCRBuy Now
Xencor
$8.36342.58%
Eva Fortea Verdejo56%
→ $37Initiates → OverweightGet Alert
10/08/2024RCUSBuy Now
Arcus Biosciences
$8.51240.78%
Eva Fortea Verdejo56%
→ $29Initiates → OverweightGet Alert
08/13/2024ITOSBuy Now
ITeos Therapeutics
$10.00210%
Eva Fortea Verdejo56%
→ $31Initiates → OverweightGet Alert
05/03/2024KNSABuy Now
Kiniksa Pharmaceuticals
$27.8422.13%
Eva Fortea Verdejo56%
→ $34Initiates → OverweightGet Alert